{"name": "Lentigen",
 "permalink": "lentigen",
 "crunchbase_url": "http://www.crunchbase.com/company/lentigen",
 "homepage_url": "http://www.lentigen.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "301.527.4200",
 "description": "",
 "created_at": "Fri Nov 05 05:08:18 UTC 2010",
 "updated_at": "Fri Nov 05 05:08:17 UTC 2010",
 "overview": "\u003Cp\u003ELentigen Corporation, a biotechnology company, engages in the development and commercialization of gene delivery technologies for human disease. It provides lentiviral vector technology for a range of therapeutic, vaccine, and research applications in biotechnology and medicine. The company offers LG690, a cell therapy for treatment of graft vs hot diseases; LG768, a cancer vaccine for the treatment of leukemia; stem cell therapy to prevent and treat medical disorders; LG631, a treatment that makes chemotheraphy for brain cancer less toxic; LG889, a steam cell therapy for hemophilia; LG611, an exact strain matched influenza vaccine for pandemic flu; LG811, an exact strain matched influenza vaccine for seasonal flu; LG747, a biosimilar erytho poieitin; and LG888, a novel factor VIII protein therapy for Hemophilia A. Lentigen Corporation was founded in 2004 and is headquartered in Gaithersburg, Maryland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0010/8790/108790v1-max-150x150.png"],
     [[192,
       75],
      "assets/images/resized/0010/8790/108790v1-max-250x250.png"],
     [[192,
       75],
      "assets/images/resized/0010/8790/108790v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Tim",
      "last_name": "Ravenscroft",
      "permalink": "tim-ravenscroft",
      "image": null}},
   {"is_past": false,
    "title": "Founder President and Chief Scientific Officer",
    "person":
     {"first_name": "Boro",
      "last_name": "Dropulic",
      "permalink": "boro-dropulic",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.2M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020101104e6b40002v\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "Lentigen Awarded $1.2M U.S. Government Grant ",
    "raised_amount": 1200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 4,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "910 Clopper Road",
    "address2": "Suite 200 S",
    "zip_code": "20878",
    "city": "Gaithersburg",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}